methylthio-adp has been researched along with Intraocular Pressure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Camden, J; Eliahu, S; Fischer, B; Lecka, J; Martín-Gil, A; Perez de Lara, MJ; Pintor, J; Sévigny, J; Weisman, GA | 1 |
1 other study(ies) available for methylthio-adp and Intraocular Pressure
Article | Year |
---|---|
2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cell Line, Tumor; Drug Stability; Humans; Hydrolysis; Intraocular Pressure; Male; Purinergic P2 Receptor Agonists; Rabbits; Receptors, Purinergic P2Y1; Structure-Activity Relationship; Turkey | 2010 |